We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,324

The Federal Circuit Criticizes A PTAB Partial Institution
  • Jones Day
  • USA
  • December 13 2017

The PTAB’s practice of partially instituting IPRs has been in the news lately, with Jones Day recently arguing against that practice at the Supreme

Inherent Obviousness: Available IPR Rationale With a High Standard
  • Jones Day
  • USA
  • December 8 2017

On November 28, 2017, the PTAB issued a final written decision upholding the patentability of U.S. Patent No. 6,667,061 (IPR2016-01096). The '061

Athens Court confirms validity of Janssen’s Patent and grants high amount of compensations
  • Dr Helen G Papaconstantinou and Partners Law Firm
  • Greece
  • December 6 2017

In Janssen Pharmaceutica N.V. against Greek pharmaceutical companies (Decision no. 21112017, June 22, 2017) the Athens Court of First Instance

Obviousness v. Anticipation: That Which Doesn’t Disclose Still Could Teach
  • Harness, Dickey & Pierce, PLC
  • USA
  • December 5 2017

In CRFD Research, Inc., v. Matal, 2016-2198 (December 5, 2017), the Federal Circuit affirmed two Final Written Decisions invaliding claims of U.S

PTAB Not Always Bound By Previous Court Decisions Regarding Patent Validity
  • Marshall Gerstein & Borun LLP
  • USA
  • December 4 2017

In Novartis AG v. Noven Pharm. Inc., Appeal 2016-1678-1679 (April 2017), Novartis appealed two PTAB decisions holding claims of two patents obvious

The Importance of Obviousness
  • Burns & Levinson LLP
  • USA
  • December 4 2017

Over a number of years, the Federal Circuit has stated the conditions for an obviousness rejection: the cited references must teach or suggest all the

Don't believe everything you read.
  • Constangy Brooks Smith & Prophete LLP
  • USA
  • December 1 2017

A boss who grabs an employee's breasts without her consent is indeed guilty of sexual harassment. Two law professors co-wrote an article that appeared

"Types" of Protection for Font and Typeface Designs
  • Sterne Kessler Goldstein & Fox PLLC
  • USA
  • November 30 2017

As a counterpoint to our article last month regarding a copyright infringement and breach of contract lawsuit filed against Target over a computer

The Bitter and the Sweet: Supreme Court Oral Argument Indicates Potential Split on Constitutionality of Inter Partes Patent Review
  • Haynes and Boone LLP
  • USA
  • November 29 2017

Is a defeated patentee at Inter Partes Review an embittered citizen whose private rights were taken without due process by a government agency

Examination Practice of Antibody-related Patent Applications in China
  • Liu, Shen & Associates
  • China
  • November 21 2017

Antibody-related drugs can be used to treat major diseases such as malignant tumors, immune diseases, infectious or allergic diseases, blood or